A pioneer in the optical imaging field with ground breaking research to his name.

Co-founder Prof. Van Dam, surgeon oncologist and professor of Surgery at Groningen University, trained at Harvard, the Mayo Clinic and NCI.

He has published the 1st in-human application of targeted fluorescence imaging in 2011 (Nature Medicine) and published more than 140 papers predominantly on the subject of clinical translation of innovative targeted optical molecular imaging.

A life science veteran with over 25 years of international experience in the industry.

Co-founder Ari is a senior life sciences veteran, with executive business development roles among others at J&J and Crucell, a vaccine company sold to J&J for $2.7B. Ari also serves as advisor to the Ministry of Economic Affairs in the Netherlands, McKinsey & Co and multiple ventures in Europe and the USA.

A creative and analytical brand storyteller with an international business background.

Tessa has a double degree in International Business and Management both from Eastern Kentucky University and Avans Hogeschool in Breda, the Netherlands. She has presented at the Academy of Business Research conference and excels in strengthening marketing efforts of startup ventures both in Europe and the USA.

A seasoned scientist, specialised in chemistry and nuclear imaging techniques.

Maarten is a senior radiochemist with a focus on the development and characterization of radiolabeled and fluorescent tracers.

He has had various roles as a scientist at the Radboud University Medical Center in Nijmegen, The Netherlands, where his research in in vivo imaging techniques had a strong translational character.

A people-focused and entrepreneurial professional with a passion for building meaningful connections, fostering inclusive cultures, and enabling people and teams to thrive. Marjolein studied Dutch Labor Law & Strategic Human Resources.

She has extensive leadership experience from healthcare and hospitality, with a background in organizational development and people-centered leadership.

Experienced financial advisor to TRACER. She gained broad experience in audit, restructuring, consulting, mergers and acquisitions, and financial management at various corporate organizations and in small and medium-sized companies.

This enables her to make a connection between the clinical studies (‘business’) and the required quality of the financial organization (‘finance’) required to enable TRACER to execute its strategy.